✨ Medicines Consent Notices
NEW ZEALAND GAZETTE
No. 78
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Engerix-B vaccine
Active Ingredient(s):
Hepatitis B surface antigen (recombinant) 20µg/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
SmithKline Beecham Biologicals SA, Rixensart, Belgium
Product:
Infanrix-HepB
Active Ingredient(s):
Tetanus toxoid 80IU/mL
Hepatitis B surface antigen (recombinant) 20µg/mL
Diphtheria toxoid (adsorbed) 60IU/mL
Detoxified pertussis toxin 50µg/mL
Pertussis filamentous haemagglutinin 50µg/mL
Pertactin 16µg/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
SmithKline Beecham Biologicals SA, Rixensart, Belgium
Product:
Twinrix Adult
Active Ingredient(s):
Hepatitis A vaccine 720EU/mL
Hepatitis B surface antigen (recombinant) 20µg/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
SmithKline Beecham Biologicals SA, Rixensart, Belgium
Product:
Twinrix Junior
Active Ingredient(s):
Hepatitis A vaccine 720EU/mL
Hepatitis B surface antigen (recombinant) 20µg/mL
Dosage Form:
Suspension for injection
New Zealand Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
SmithKline Beecham Biologicals SA, Rixensart, Belgium
Dated this 10th day of July 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5089
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Beta
Active Ingredient(s):
Betamethasone valerate 0.1215%w/w equivalent to betamethasone 0.1%
Dosage Form:
Topical cream
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer(s):
Pacific Pharmaceuticals Limited, Mount Wellington, Auckland
PSM Healthcare Limited, Wiri, Auckland
Product:
Beta
Active Ingredient(s):
Betamethasone valerate 0.1215%w/w equivalent to betamethasone 0.1%
Dosage Form:
Topical ointment
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer(s):
Pacific Pharmaceuticals Limited, Mount Wellington, Auckland
PSM Healthcare Limited, Wiri, Auckland
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 78
Gazette.govt.nz —
NZ Gazette 2000, No 78
✨ LLM interpretation of page content
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare10 July 2000
Medicines, Consent, Distribution, Hepatitis B, Vaccines
- G. R. Boyd, Chief Advisor, Safety and Regulation
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines, Consent, Distribution, Betamethasone